FCS physicians and senior leaders are co-authors of a study that confirms the effectiveness of trilaciclib for the treatment of adult patients with Extensive-Stage Small Cell Lung Cancer. Trilaciclib is the first FDA-approved therapy in its class to help protect bone marrow cells from damage caused by chemotherapy.
Lucio Gordan, MD, President & Managing Physician of Florida Cancer Specialists & Research Institute, LLC (FCS), talked with Kevin Keegan, General Manager of Oncology Business with Illumina, about how FCS is bringing precision oncology through analysis of real-world data, innovative technology and research to cancer patients being treated in community settings.
Smoothies can be a great way to get fruit and vegetables into your diet, and even grains (more about that later). But are they as good as actually eating those fruits and vegetables?
1 in 5 Americans will develop skin cancer before 70, and two people die from skin cancer every hour. Not only is skin cancer deadly several myths prevent people from practicing prevention.
FCS Top News Updates
FCS Expands Footprint Into St. Lucie County, Breaks Ground For New Cancer Center in Tradition